NEW YORK, May 7, 2012 /PRNewswire/ — Intellect Neurosciences, Inc. (ILNS.PK), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment …
Go here to read the rest:
Intellect ... continue reading
NEW YORK (Reuters Health) – Daily use of antioxidants including vitamin C and vitamin E didn't improve thinking and memory skills in people with Alzheimer's disease, in a new study. Researchers found that some patients taking antioxidants actually had faster declines in memory over the four-month study compared to those ... continue reading
NEW YORK, March 13, 2012 /PRNewswire/ — The Alzheimer's Association, New York City Chapter will host a free community event, open to the public, featuring a panel of experts who will explore the role …
Follow this link:
... continue reading
if !IE–endif–Content on this page requires a newer version of Adobe Flash Player.if !IE–endif– NEW YORK (TheStreet) — Past truly is prologue. In mid-2008, I was short Elan and getting crushed. My thesis was that Phase II data for the company's lead drug candidate, a monoclonal antibody called bapineuzumab for ... continue reading
NEW YORK , Jan. 3, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Alzheimer disease – New drugs, markets and companies http://www.reportlinker.com/p0203533/Alzheimer-disease—New-drugs-markets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationSummaryAlzheimer’s …
View original post here:
Alzheimer Disease – New Drugs, ... continue reading